Abstract
Objective
This study investigated the impacts of SIRT1 activation on rheumatoid arthritis (RA)-related angiogenesis.
Methods
HUVECs were cultured by different human serum. Intracellular metabolites were quantified by UPLC-MS. Next, HUVECs and rat vascular epithelial cells under different inflammatory conditions were treated by a SIRT1 agonist resveratrol (RSV). Cytokines and biochemical indicators were detected by corresponding kits. Protein and mRNA expression levels were assessed by immunoblotting and PCR methods, respectively. Angiogenesis capabilities were evaluated by migration, wound-healing and tube-formation experiments. To down-regulate certain signals, gene-specific siRNA were applied.
Results
Metabolomics study revealed the accelerated glycolysis in RA serum-treated HUVECs. It led to ATP accumulation, but did not affect GTP levels. RSV inhibited pro-angiogenesis cytokines production and glycolysis in both the cells, and impaired the angiogenesis potentials. These effects were mimicked by an energy metabolism interrupter bikini in lipopolysaccharide (LPS)-primed HUVECs, largely independent of HIF-1α. Both RSV and bikinin can inhibit the activation of the GTP-dependent pathway Rho/ROCK and reduce VEGF production. Abrogation of RhoA signaling reinforced HIF-1α silencing-brought changes in LPS-stimulated HUVECs, and overshadowed the anti-angiogenesis potentials of RSV.
Conclusion
Glycolysis provides additional energy to sustain Rho/ROCK activation in RA subjects, which promotes VEGF-driven angiogenesis and can be inhibited by SIRT1 activation.
Similar content being viewed by others
Data availability
The data that support the findings are included in the supplementary information.
Abbreviations
- RA:
-
Rheumatoid arthritis
- VECs:
-
Vascular epithelial cells
- FBS:
-
Fetal bovine serum
- RSV:
-
Resveratrol
- LPS:
-
Lipopolysaccharide
- MDA:
-
Malondialdehyde
- GSH:
-
Reduced glutathione
- LDH:
-
Lactate dehydrogenase
- SOD:
-
Superoxide dismutase
- HUVECs:
-
Human umbilical vein endothelial cells
- MRM:
-
Multiple reaction monitoring
- AIA:
-
Adjuvant-induced arthritis
- PCA:
-
Principal component analysis
- OPLS-DA:
-
Orthogonal projections to latent structures—discriminant analysis
- VIP:
-
Variable importance in the projection
References
Shiozawa S, Tsumiyama K, Yoshida K, Hashiramoto A. Pathogenesis of joint destruction in rheumatoid arthritis. Arch Immunol Ther Exp. 2011;59:89–95.
Scherer HU, Häupl T, Burmester GR. The etiology of rheumatoid arthritis. J Autoimmun. 2020;110: 102400.
Sparks JA. Rheumatoid arthritis. Ann Intern Med. 2019;170:1–16.
Fang Q, Zhou C, Nandakumar KS. Molecular and cellular pathways contributing to joint damage in rheumatoid arthritis. Mediators Inflamm. 2020;2020:3830212.
Aletaha D, Smolen JS. Diagnosis and management of rheumatoid arthritis: a review. JAMA. 2018;320:1360–72.
Huang J, Fu X, Chen X, Li Z, Huang Y, Liang C. Promising therapeutic targets for treatment of rheumatoid arthritis. Front Immunol. 2021;12: 686155.
Jia W, Wu W, Yang D, Xiao C, Huang M, Long F, Su Z, et al. GATA4 regulates angiogenesis and persistence of inflammation in rheumatoid arthritis. Cell Death Dis. 2018;9:503.
Wang Y, Wu H, Deng R. Angiogenesis as a potential treatment strategy for rheumatoid arthritis. Eur J Pharmacol. 2021;910: 174500.
Lee P, Chandel NS, Simon MC. Cellular adaptation to hypoxia through hypoxia inducible factors and beyond. Nat Rev Mol Cell Biol. 2020;21:268–83.
Choudhry H, Harris AL. Advances in hypoxia-inducible factor biology. Cell Metab. 2018;27:281–98.
Kretschmer M, Rüdiger D, Zahler S. Mechanical aspects of angiogenesis. Cancers. 2021;13:4987.
Eelen G, de Zeeuw P, Treps L, Harjes U, Wong BW, Carmeliet P. Endothelial cell metabolism. Physiol Rev. 2018;98:3–58.
Jiang TT, Ji CF, Cheng XP, Gu SF, Wang R, Li Y, Zuo J, Han J. α-Mangostin alleviated hif-1α-mediated angiogenesis in rats with adjuvant-induced arthritis by suppressing aerobic glycolysis. Front Pharmacol. 2021;12:785586.
Wang DD, He CY, Wu YJ, Xu L, Shi C, Olatunji OJ, Zuo J, et al. AMPK/SIRT1 deficiency drives adjuvant-induced arthritis in rats by promoting glycolysis-mediated monocytes inflammatory polarization. J Inflamm Res. 2022;15:4663–75.
Lei M, Tao MQ, Wu YJ, Xu L, Yang Z, Li Y, Olatunji OJ, et al. Metabolic Enzyme Triosephosphate isomerase 1 and nicotinamide phosphoribosyltransferase, two independent inflammatory indicators in rheumatoid arthritis: evidences from collagen-induced arthritis and clinical samples. Front Immunol. 2022;12:795626.
Yu Q, Dong L, Li Y, Liu G. SIRT1 and HIF1α signaling in metabolism and immune responses. Cancer Lett. 2018;418:20–6.
Xia N, Daiber A, Förstermann U, Li H. Antioxidant effects of resveratrol in the cardiovascular system. Br J Pharmacol. 2017;174:1633–46.
Jaklová Dytrtová J, Straka M, Bělonožníková K, Jakl M, Ryšlavá H. Does resveratrol retain its antioxidative properties in wine? Redox behaviour of resveratrol in the presence of Cu(II) and tebuconazole. Food Chem. 2018;262:221–5.
Grzeczka A, Kordowitzki P. Resveratrol and SIRT1: Antiaging cornerstones for oocytes? Nutrients. 2022;14:5101.
Craveiro M, Cretenet G, Mongellaz C, Matias MI, Caron O, de Lima MCP, Zimmermann VS, et al. Resveratrol stimulates the metabolic reprogramming of human CD4+ T cells to enhance effector function. Sci Signal. 2017;10:3024.
Koronowski KB, Khoury N, Saul I, Loris ZB, Cohan CH, Stradecki-Cohan HM, Dave KR, et al. Neuronal SIRT1 (silent information regulator 2 homologue 1) regulates glycolysis and mediates resveratrol-induced ischemic tolerance. Stroke. 2017;48:3117–25.
Inoue H, Nakata R. Resveratrol targets in inflammation. Endocr Metab Immune Disord Drug Targets. 2015;15:186–95.
Wang G, Xie X, Yuan L, Qiu J, Duan W, Xu B, Chen X. Resveratrol ameliorates rheumatoid arthritis via activation of SIRT1-Nrf2 signaling pathway. BioFactors. 2020;46:441–53.
Yang G, Chang CC, Yang Y, Yuan L, Xu L, Ho CT, Li S. Resveratrol alleviates rheumatoid arthritis via reducing ROS and inflammation, inhibiting MAPK signaling pathways, and suppressing angiogenesis. J Agric Food Chem. 2018;66:12953–60.
Liu B, Pang L, Ji Y, Fang L, Tian CW, Chen J, Chen C, et al. MEF2A is the trigger of resveratrol exerting protection on vascular endothelial cell. Front Cardiovasc Med. 2022;8:775392.
Rameshrad M, Imenshahidi M, Razavi BM, Iranshahi M, Hosseinzadeh H. Bisphenol A vascular toxicity: Protective effect of Vitis vinifera (grape) seed extract and resveratrol. Phytother Res. 2018;32:2396–407.
Merajver SD, Usmani SZ. Multifaceted role of Rho proteins in angiogenesis. J Mammary Gland Biol Neoplasia. 2005;10:291–8.
Fang G, Zhang P, Liu J, Zhang X, Zhu X, Li R, Wang H. Inhibition of GSK-3β activity suppresses HCC malignant phenotype by inhibiting glycolysis via activating AMPK/mTOR signaling. Cancer Lett. 2019;463:11–26.
Libby P. Inflammatory mechanisms: the molecular basis of inflammation and disease. Nutr Rev. 2007;65:S140–6.
Weyand CM, Goronzy JJ. Immunometabolism in the development of rheumatoid arthritis. Immunol Rev. 2020;294:177–87.
Nazari-Khanamiri F, Ghasemnejad-Berenji M. Resveratrol may ameliorate rheumatoid arthritis via the STAT3/HIF-1/VEGF molecular pathway. J Food Biochem. 2022;46: e14182.
Peng H, Wei M, Huang L, Yan Y, Li Q, Li S, Wu Y, et al. Maternal obesity inhibits placental angiogenesis by down-regulating the SIRT1/PGC-1α pathway. Ann Transl Med. 2022;10:446.
Zhu T, Xie WJ, Wang L, Jin XB, Meng XB, Sun GB, Sun XB. Notoginsenoside R1 activates the NAMPT-NAD+-SIRT1 cascade to promote postischemic angiogenesis by modulating Notch signaling. Biomed Pharmacother. 2021;140:111693.
Zheng XW, Shan CS, Xu QQ, Wang Y, Shi YH, Wang Y, Zheng GQ. Buyang Huanwu decoction targets SIRT1/VEGF pathway to promote angiogenesis after cerebral ischemia/reperfusion injury. Front Neurosci. 2018;12:911.
Li X, Wu G, Han F, Wang K, Bai X, Jia Y, Li Z, et al. SIRT1 activation promotes angiogenesis in diabetic wounds by protecting endothelial cells against oxidative stress. Arch Biochem Biophys. 2019;661:117–24.
Fan D, Liu C, Guo Z, Huang K, Peng M, Li N, Luo H, et al. Resveratrol promotes angiogenesis in a FoxO1-dependent manner in hind limb ischemia in mice. Molecules. 2021;26:7528.
Huang X, Sun J, Chen G, Niu C, Wang Y, Zhao C, Sun J, et al. Resveratrol promotes diabetic wound healing via SIRT1-FOXO1-c-Myc signaling pathway-mediated angiogenesis. Front Pharmacol. 2019;10:421.
Zhang W, Huang Q, Zeng Z, Wu J, Zhang Y, Chen Z. Sirt1 inhibits oxidative stress in vascular endothelial cells. Oxid Med Cell Longev. 2017;2017:7543973.
Kim YW, Byzova TV. Oxidative stress in angiogenesis and vascular disease. Blood. 2014;123:625–31.
Narumiya S, Thumkeo D. Rho signaling research: history, current status and future directions. FEBS Lett. 2018;592:1763–76.
Liu J, Wada Y, Katsura M, Tozawa H, Erwin N, Kapron CM, Bao G, et al. Rho-associated coiled-coil kinase (ROCK) in molecular regulation of angiogenesis. Theranostics. 2018;8:6053–69.
Zuo J, Wang X, Liu Y, Ye J, Liu Q, Li Y, Li S. Integrating network pharmacology and metabolomics study on anti-rheumatic mechanisms and antagonistic effects against methotrexate-induced toxicity of Qing-Luo-Yin. Front Pharmacol. 2018;9:1472.
Zuo J, Tao MQ, Wu XY, Jiang TT, Olatunji OJ, Dong J, Han J, et al. Securidaca inappendiculata-derived xanthones protected joints from degradation in male rats with collagen-induced arthritis by regulating PPAR-γ signaling. J Inflamm Res. 2021;14:395–411.
Acknowledgements
This work was supported by the National Natural Science Foundation of China (81973828, 82274465), Key Project of Natural Science Foundation of Anhui Province for College Scholar (KJ2020A0868) and the Open Fund of Key Laboratory of Anti-Inflammatory and Immune Medicine, Ministry of Education, China (Anhui Medical University) (KFJJ-2020-08).
Author information
Authors and Affiliations
Contributions
JZ and JH conceived the idea. QL and TW collected clinical samples. TTJ and CLJ performed the majority of the experiments. LJY, MKS and YL participated in all the experiments. JZ and OJO wrote the manuscript. OJO and JH proofread the manuscript. All the authors gave final approval of the version to be published.
Corresponding authors
Ethics declarations
Conflict of interest
The authors report no conflict of interest.
Additional information
Responsible Editor: Jason J. McDougall.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Jiang, TT., Ji, CL., Yu, LJ. et al. Resveratrol-induced SIRT1 activation inhibits glycolysis-fueled angiogenesis under rheumatoid arthritis conditions independent of HIF-1α. Inflamm. Res. 72, 1021–1035 (2023). https://doi.org/10.1007/s00011-023-01728-w
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00011-023-01728-w